BAJAJ BROKING

Notification
No new Notification messages
Vishal Mega Mart IPO is Open!
Apply for the Vishal Mega Mart IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
lincoln pharma ltd stock

LINCOLN PHARMA LTD Share Price

918.85 -23.60 (-2.50%)
Dec 12 2024 03:30 PM Pharmaceuticals NSE: LINCOLN

LINCOLN PHARMA LTD Share Price Update

As of the latest trading session, LINCOLN PHARMA LTD share price is currently at 918.85, which is down by -23.60 from its previous closing. Today, the stock has fluctuated between 910.00 and 963.95. Over the past year, LINCOLN PHARMA LTD has achieved a return of 42.62 %. In the last month alone, the return has been 43.39 %. Read More...

LINCOLN PHARMA LTD Performance

Day Range

Low910.00 High963.95
918.85

52 Week Range

Low 534.80 High 979.50
918.85

LINCOLN PHARMA LTD Share Price

11596

531633

LINCOLN

img img img img
No Data Available

Open Price

959.00

Prev. Close

942.45

Volume (Shares)

95436.00

Total traded value

876.91

Upper Circuit

1036.65

Lower Circuit

848.20

Note: The current prices & values are delayed, Login to your account for live updates.

LINCOLN PHARMA LTD Fundamentals


(Standalone)

Market Cap (Cr) 1840.43
PE Ratio (TTM) 19.05
Book Value / Share 319.15
Beta 0.86
ROE 17.04%
EPS (TTM) 48.25
Dividend Yield 0.20%
Net Profit Qtr (Cr) 26.33

LINCOLN PHARMA LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 161.21
Operating Expense 136.41
Net Profit 26.33
Net Profit Margin (%) 16.33
Earnings Per Share (EPS) 13.15
EBITDA 38.35
Effective Tax Rate (%) 24.29
Particulars JUN 2024 (Values in Cr)
Revenue 147.28
Operating Expense 128.21
Net Profit 23.67
Net Profit Margin (%) 16.07
Earnings Per Share (EPS) 11.82
EBITDA 33.14
Effective Tax Rate (%) 19.70
Particulars MAR 2024 (Values in Cr)
Revenue 142.49
Operating Expense 127.30
Net Profit 18.60
Net Profit Margin (%) 13.05
Earnings Per Share (EPS) 9.28
EBITDA 25.41
Effective Tax Rate (%) 16.29
Particulars DEC 2023 (Values in Cr)
Revenue 146.45
Operating Expense 119.75
Net Profit 28.04
Net Profit Margin (%) 19.14
Earnings Per Share (EPS) 14.00
EBITDA 40.67
Effective Tax Rate (%) 25.64
Particulars SEP 2023 (Values in Cr)
Revenue 155.99
Operating Expense 127.81
Net Profit 27.65
Net Profit Margin (%) 17.72
Earnings Per Share (EPS) 13.81
EBITDA 39.83
Effective Tax Rate (%) 24.97
Particulars MAR 2024 (Values in Cr)
Revenue 580.55
Operating Expense 492.72
Net Profit 93.30
Net Profit Margin (%) 16.07
Earnings Per Share (EPS) 46.58
EBITDA 134.32
Effective Tax Rate (%) 23.67
Particulars MAR 2023 (Values in Cr)
Revenue 510.31
Operating Expense 432.34
Net Profit 72.90
Net Profit Margin (%) 14.28
Earnings Per Share (EPS) 36.40
EBITDA 111.66
Effective Tax Rate (%) 27.43
Particulars MAR 2022 (Values in Cr)
Revenue 472.08
Operating Expense 386.15
Net Profit 69.36
Net Profit Margin (%) 14.69
Earnings Per Share (EPS) 34.63
EBITDA 105.47
Effective Tax Rate (%) 27.69
Particulars MAR 2021 (Values in Cr)
Revenue 422.91
Operating Expense 344.98
Net Profit 62.25
Net Profit Margin (%) 14.71
Earnings Per Share (EPS) 31.08
EBITDA 92.78
Effective Tax Rate (%) 25.60
Particulars MAR 2020 (Values in Cr)
Revenue 376.09
Operating Expense 324.17
Net Profit 49.56
Net Profit Margin (%) 13.17
Earnings Per Share (EPS) 24.78
EBITDA 71.50
Effective Tax Rate (%) 22.60
Particulars MAR 2024 (Values in Cr)
Book Value / Share 295.98
ROE % 17.04
ROCE % 22.35
Total Debt to Total Equity 0.00
EBITDA Margin 23.14
Particulars MAR 2023 (Values in Cr)
Book Value / Share 250.86
ROE % 15.59
ROCE % 21.61
Total Debt to Total Equity 0.00
EBITDA Margin 21.88
Particulars MAR 2022 (Values in Cr)
Book Value / Share 216.12
ROE % 17.36
ROCE % 24.03
Total Debt to Total Equity 0.00
EBITDA Margin 22.34
Particulars MAR 2021 (Values in Cr)
Book Value / Share 182.92
ROE % 18.32
ROCE % 24.60
Total Debt to Total Equity 0.01
EBITDA Margin 21.89
Particulars MAR 2020 (Values in Cr)
Book Value / Share 156.54
ROE % 17.67
ROCE % 22.03
Total Debt to Total Equity 0.07
EBITDA Margin 19.81
Particulars MAR 2024 (Values in Cr)
Book Value / Share 295.98
ROE % 17.04
ROCE % 22.35
Total Debt to Total Equity 0.00
EBITDA Margin 23.14
Particulars MAR 2023 (Values in Cr)
Book Value / Share 250.86
ROE % 15.59
ROCE % 21.60
Total Debt to Total Equity 0.00
EBITDA Margin 21.88
Particulars MAR 2022 (Values in Cr)
Book Value / Share 216.12
ROE % 17.35
ROCE % 24.02
Total Debt to Total Equity 0.00
EBITDA Margin 22.34
Particulars MAR 2021 (Values in Cr)
Book Value / Share 182.92
ROE % 18.56
ROCE % 24.90
Total Debt to Total Equity 0.01
EBITDA Margin 21.94
Particulars MAR 2020 (Values in Cr)
Book Value / Share 152.25
ROE % 17.48
ROCE % 21.54
Total Debt to Total Equity 0.07
EBITDA Margin 19.01
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 13.83
Total Assets 700.29
Total Liabilities 700.29
Total Equity 592.83
Share Outstanding 20029728
Price to Book Ratio 1.98
Return on Assets (%) 13.32
Return on Capital (%) 15.71
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 34.31
Total Assets 587.42
Total Liabilities 587.42
Total Equity 502.47
Share Outstanding 20029728
Price to Book Ratio 1.35
Return on Assets (%) 12.41
Return on Capital (%) 14.45
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 18.79
Total Assets 534.35
Total Liabilities 534.35
Total Equity 432.87
Share Outstanding 20029728
Price to Book Ratio 1.44
Return on Assets (%) 12.97
Return on Capital (%) 15.95
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 13.84
Total Assets 452.35
Total Liabilities 452.35
Total Equity 366.39
Share Outstanding 20029728
Price to Book Ratio 1.23
Return on Assets (%) 13.76
Return on Capital (%) 16.97
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 14.58
Total Assets 389.38
Total Liabilities 389.38
Total Equity 313.47
Share Outstanding 20000000
Price to Book Ratio 0.88
Return on Assets (%) 13.21
Return on Capital (%) 16.17
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 13.38
Total Assets 700.14
Total Liabilities 700.14
Total Equity 592.83
Share Outstanding 20029728
Price to Book Ratio 1.98
Return on Assets (%) 13.32
Return on Capital (%) 15.71
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 33.84
Total Assets 587.25
Total Liabilities 587.25
Total Equity 502.47
Share Outstanding 20029728
Price to Book Ratio 1.35
Return on Assets (%) 12.41
Return on Capital (%) 14.45
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 18.43
Total Assets 534.11
Total Liabilities 534.11
Total Equity 432.87
Share Outstanding 20029728
Price to Book Ratio 1.44
Return on Assets (%) 12.98
Return on Capital (%) 15.95
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 13.43
Total Assets 451.80
Total Liabilities 451.80
Total Equity 366.39
Share Outstanding 20029728
Price to Book Ratio 1.23
Return on Assets (%) 13.77
Return on Capital (%) 16.97
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 11.21
Total Assets 367.20
Total Liabilities 367.20
Total Equity 304.49
Share Outstanding 20000000
Price to Book Ratio 0.88
Return on Assets (%) 13.49
Return on Capital (%) 16.05
Particulars MAR 2024 (Values in Cr)
Net Income 122.24
Cash from Operations 89.36
Cash from Investing -57.34
Cash from Financing -5.18
Net change in Cash 0.69
Free Cash Flow 128.84
Particulars MAR 2023 (Values in Cr)
Net Income 100.47
Cash from Operations 68.87
Cash from Investing -36.64
Cash from Financing -4.50
Net change in Cash -1.88
Free Cash Flow 83.13
Particulars MAR 2022 (Values in Cr)
Net Income 95.93
Cash from Operations 99.82
Cash from Investing -78.08
Cash from Financing -2.55
Net change in Cash -4.50
Free Cash Flow 145.35
Particulars MAR 2021 (Values in Cr)
Net Income 83.72
Cash from Operations 88.76
Cash from Investing -64.22
Cash from Financing -5.74
Net change in Cash -0.70
Free Cash Flow 97.51
Particulars MAR 2020 (Values in Cr)
Net Income 67.23
Cash from Operations 90.22
Cash from Investing -30.88
Cash from Financing -37.75
Net change in Cash 6.77
Free Cash Flow 97.91
Particulars MAR 2024 (Values in Cr)
Net Income 122.24
Cash from Operations 89.37
Cash from Investing -57.34
Cash from Financing -5.17
Net change in Cash 0.72
Free Cash Flow 128.84
Particulars MAR 2023 (Values in Cr)
Net Income 100.45
Cash from Operations 68.76
Cash from Investing -36.64
Cash from Financing -4.50
Net change in Cash -1.98
Free Cash Flow 83.02
Particulars MAR 2022 (Values in Cr)
Net Income 95.92
Cash from Operations 99.82
Cash from Investing -78.08
Cash from Financing -2.56
Net change in Cash -4.46
Free Cash Flow 145.34
Particulars MAR 2021 (Values in Cr)
Net Income 83.67
Cash from Operations 88.84
Cash from Investing -64.39
Cash from Financing -5.73
Net change in Cash -0.74
Free Cash Flow 97.59
Particulars MAR 2020 (Values in Cr)
Net Income 64.04
Cash from Operations 84.69
Cash from Investing -28.99
Cash from Financing -38.10
Net change in Cash 3.61
Free Cash Flow 91.35
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.16 37.45 3.55 499.34 37.54 / 77.70
BLISS GVS PHARMA LTD 151.80 19.00 1.58 1598.94 92.25 / 172.40
CIPLA LTD 1454.20 25.44 4.14 117443.01 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 410.00 142.36 4.15 1206.67 145.00 / 440.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.16 56.66 11.07 499.34 37.54 / 77.70
AMRUTAJAN HEALTH LTD 749.55 45.59 7.27 2167.00 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6595.05 128.08 24.26 16487.63 4050.15 / 8139.85
BLISS GVS PHARMA LTD 151.80 19.79 1.56 1598.94 92.25 / 172.40

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 936.60
  • 26 Days 756.70
  • 10 Days 852.60
  • 50 Days 717.00
  • 12 Days 829.60
  • 100 Days 696.10
  • 20 Days 777.20
  • 200 Days 686.60
945.27
PIVOT
First Resistance 954.78
Second Resistance 967.12
Third Resistance 976.63
First Support 932.93
Second Support 923.42
Third Support 911.08
RSI 83.78
MACD 72.96
Commodity Channel Index (CCI) 121.87
ADX 55.37
Williams % R -10.06

Over 1 Month

down

43.39

Over 3 Months

down

18.89

Over 6 Months

down

53.94

Over 1 Year

down

42.62

Over 3 Years

down

37.42

Over 5 Years

down

41.16

LINCOLN PHARMA LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

LINCOLN PHARMA LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
45.03
Promoter Holdings
49.77
FII
5.19
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Munjal Mahendrabhai Patel Shareholding of Promoter and Promoter Group 2678800.0 13.37
Aashish Rajanibhai Patel Shareholding of Promoter and Promoter Group 2122902.0 10.6
Rajanikant Gulabdas Patel Shareholding of Promoter and Promoter Group 756801.0 3.78
Mahendrabhai Gulabdas Patel Shareholding of Promoter and Promoter Group 675000.0 3.37
Sunmed Corporation Llp Shareholding of Promoter and Promoter Group 500000.0 2.5
Kailashben Mahendrabhai Patel Shareholding of Promoter and Promoter Group 480000.0 2.4
Kishor M. Shah Public Shareholding 478400.0 2.39
Downtown Travels Llp Shareholding of Promoter and Promoter Group 475000.0 2.37
Hashmukhbhai Ishwarlal Patel Shareholding of Promoter and Promoter Group 373600.0 1.87
Anand Arvinbhai Patel Shareholding of Promoter and Promoter Group 332000.0 1.66
Rimo Capital Fund Lp Public Shareholding 266450.0 1.33
Dheeraj Kumar Lohia Public Shareholding 263637.0 1.32
Shivani Ashish Patel Shareholding of Promoter and Promoter Group 206475.0 1.03
Mansi Munjal Patel Shareholding of Promoter and Promoter Group 200000.0 1.0
Hansaben Arvindbhai Patel Shareholding of Promoter and Promoter Group 177200.0 0.88
Patel Nishitkumar Maheshbhai Shareholding of Promoter and Promoter Group 153400.0 0.77
Dharmisthaben Bhagirath Patel Shareholding of Promoter and Promoter Group 124459.0 0.62
Arvindbhai Gulabdas Patel Shareholding of Promoter and Promoter Group 111000.0 0.55
Downtown Finance Pvt. Ltd. Shareholding of Promoter and Promoter Group 106000.0 0.53
Renukaben Maheshbhai Patel Shareholding of Promoter and Promoter Group 98047.0 0.49
Patel Aniruddh H Shareholding of Promoter and Promoter Group 86200.0 0.43
Jigar Hasmukhbhai Patel Shareholding of Promoter and Promoter Group 86200.0 0.43
Mihir Viththalbhai Patel Shareholding of Promoter and Promoter Group 82669.0 0.41
Dharmistaben Hasmukhbhai Patel Shareholding of Promoter and Promoter Group 65003.0 0.32
Nidhi Mahendrabhai Patel Shareholding of Promoter and Promoter Group 54000.0 0.27
Bhagirathbhai Tribhovandas Patel Shareholding of Promoter and Promoter Group 24500.0 0.12
Amar Arvindbhai Patel Shareholding of Promoter and Promoter Group 0.0 0.0
Kalpanaben Rajnibhai Patel Shareholding of Promoter and Promoter Group 0.0 0.0
Shardaben Gulabdas Patel Shareholding of Promoter and Promoter Group 0.0 0.0
Patel Siddharth Rajanikant Shareholding of Promoter and Promoter Group 0.0 0.0
Yogeshkumar Ishwerlal Patel Shareholding of Promoter and Promoter Group 309.0 0.0
Minaben Yogeshkumar Patel Shareholding of Promoter and Promoter Group 365.0 0.0

LINCOLN PHARMA LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-09-15 1.5 Final 2023-09-16 Equity shares 2022-09-15 1.5 Final 2022-09-17 Equity shares 2021-09-16 1.5 Final 2021-09-18 Equity shares 2020-03-05 1.5 Interim 2020-03-06 Equity shares 2019-09-19 1.5 Final 2019-09-21 Equity shares 2018-09-19 1.5 Final 2018-09-22 Equity shares 2017-09-21 1.2 Final 2017-09-23 Equity shares 2016-09-23 1.0 Final 2016-09-27 Equity shares 2015-09-23 1.0 Final 2015-09-26 Equity shares 2014-09-25 0.6 Final 2014-09-27 Equity shares 2013-09-19 0.6 Final 2013-09-21 Equity shares 2012-09-20 0.6 Final 2012-09-22 Equity shares 2011-09-22 0.6 Final 2011-09-24 Equity shares 2010-09-23 1.2 Final 2010-09-25 Equity shares 2009-09-17 1.2 Final 2009-09-19 Equity shares 2008-09-18 0.24 Final 2008-09-20 Equity shares 2007-09-20 0.24 Final 2007-09-22 Equity shares 2006-09-14 0.0 Final 2006-09-16 Equity shares 2005-08-25 0.0 Final 2005-08-29 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date
2009-03-19 2.0 10.0 2009-03-26 2006-02-08 10.0 2.0 2006-02-16

Learn More About Stocks

About LINCOLN PHARMA LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by LINCOLN PHARMA LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Lincoln Pharmaceuticals Ltd?

Answer Field

The share price of Lincoln Pharmaceuticals Ltd for NSE is ₹ 918.85 and for BSE is ₹ 918.6.

What is the Market Cap of Lincoln Pharmaceuticals Ltd?

Answer Field

The market cap of Lincoln Pharmaceuticals Ltd for NSE is ₹ 18,40.43 Cr. and for BSE is ₹ 18,39.93 Cr. as of now.

What is the 52 Week High and Low of Lincoln Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Lincoln Pharmaceuticals Ltd for NSE is ₹ 979.50 and ₹ 534.80 and for BSE is ₹ 975.00 and ₹ 498.00.

How to Buy Lincoln Pharmaceuticals Ltd share?

Answer Field

You can trade in Lincoln Pharmaceuticals Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Lincoln Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been 42.62%.

What is the Current Share Price of Lincoln Pharmaceuticals Ltd?

Answer Field

Lincoln Pharmaceuticals Ltd share price is for NSE ₹ 918.85 & for BSE ₹ 918.6 as on Dec 12 2024 03:30 PM.

What is the Market Cap of Lincoln Pharmaceuticals Ltd Share?

Answer Field

The market cap of Lincoln Pharmaceuticals Ltd for NSE ₹ 18,40.43 & for BSE ₹ 18,39.93 as on Dec 12 2024 03:30 PM.

What is the P/E Ratio of Lincoln Pharmaceuticals Ltd Share?

Answer Field

As on Dec 12 2024 03:30 PM the price-to-earnings (PE) ratio for Lincoln Pharmaceuticals Ltd share is 19.05.

What is the PB ratio of Lincoln Pharmaceuticals Ltd Share?

Answer Field

As on Dec 12 2024 03:30 PM, the price-to-book (PB) ratio for Lincoln Pharmaceuticals Ltd share is 319.15.

How to Buy Lincoln Pharmaceuticals Ltd Share?

Answer Field

You can trade in Lincoln Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Lincoln Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Lincoln Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Lincoln Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader